Position in BNTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,672,387
+$266,929 QoQ
Shares Held
17,973
+13.7% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#118
of 282 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in BNTX Over Time
Shares Held
Position Value (USD)
Derivatives in BNTX
reported options exposure · as of Dec 31, 2024CallValue
$9,685,750
CallShares
85,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026WELLS FARGO & COMPANY/MN holds $1,567,774,320 across 417 Biotechnology names. BNTX ranks #109 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
749,528 | $372,313,040 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
1,390,428 | $108,828,797 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
310,047 | $93,333,446 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
140,802 | $87,795,677 | |
| 5 | EXEL |
Exelixis, Inc.
|
717,840 | $39,057,673 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
178,780 | $33,481,916 | |
| 7 | ARGX |
Argenx SE
|
34,453 | $31,964,458 | |
| 8 | INCY |
Incyte Corp
|
255,064 | $28,914,053 |
All Filings in BNTX
Export CSV
30 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,672,387 | 17,973 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $1,405,458 | 15,813 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $542,829 | 5,702 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $622,487 | 6,312 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $871,349 | 8,184 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,759,004 | 19,317 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $9,685,750 | 85,000 | Call | Defined | 2025-02-13 | |
| 2024-12-31 | $2,716,567 | 23,840 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $3,529,843 | 29,720 | Shares | Defined | 2024-11-13 | |
| 2024-09-30 | $10,095,450 | 85,000 | Call | Defined | 2024-11-13 | |
| 2024-06-30 | $6,435,389 | 80,082 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $7,857,853 | 85,180 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $8,672,325 | 82,171 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $8,359,194 | 76,944 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $7,588,124 | 70,306 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $7,158,663 | 57,467 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $7,688,708 | 51,183 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $8,141,626 | 60,362 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $7,958,658 | 53,378 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $11,332,346 | 66,442 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $21,894,695 | 84,929 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $21,668,307 | 79,374 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $16,503,537 | 73,716 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $6,942,517 | 63,582 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $6,193,644 | 75,977 | Shares | Defined | 2021-02-09 | |
| 2020-12-31 | $4,891,200 | 60,000 | Put | Defined | 2021-02-09 | |
| 2020-09-30 | $788,044 | 11,383 | Shares | Defined | 2020-11-05 | |
| 2020-06-30 | $631,024 | 9,455 | Shares | Defined | 2020-08-13 | |
| 2020-06-30 | $38,000 | 20,000 | Put | Defined | 2020-08-13 | |
| 2020-03-31 | $19,330 | 331 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||